- 1 analyst, 1 voteThe latest Buy, Hold or Sell from every analyst covering a stock.
- Price targetsTheir average target, the range, and the upside against today's price.
- Radar picks →The stocks our model scores highest in each index.
Russell 2000 analyst ratings
1,952 stocks · 1,852 covered · 15,462 votes ·
Ranking as of analyst data of 7 Nov 2026
| #Stock | Price · day | Buy / Hold / Sell | Avg target · range (USD) | Upside | Latest target report | Next earnings | Data status | Analysts | Report dates |
|---|---|---|---|---|---|---|---|---|---|
| 13.64+11.53% | Buy 13 · Hold 1 · Sell 0 · 93% Buy | 28.1518.00–50.00 | +106.4%+14.51 USD | 27 OctPartial coverage · checked 6 Nov | 16 NovEstimated | Partial coverage6 Nov 06:00 ET | 1614 firms | avg 4 Sep6 Mar 2026 – 27 Oct 2026 | |
102BKVBKV | 17.55−2.99% | Buy 13 · Hold 0 · Sell 0 · 100% Buy | 34.3629.00–39.00 | +95.8%+16.81 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:07 ET | 1514 firms | avg 11 Jul5 Feb 2026 – 19 Oct 2026 |
| 130.96−5.66% | Buy 13 · Hold 2 · Sell 0 · 87% Buy | 187.79140.00–225.00 | +43.4%+56.83 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:44 ET | 1717 firms | avg 15 Sep14 May 2026 – 30 Oct 2026 | |
| 0.84+6.54% | Buy 13 · Hold 3 · Sell 0 · 81% Buy | 11.605.00–15.00 | +1,281.0%+10.76 USD | 26 OctPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 03:34 ET | 1616 firms | avg 23 Jul18 Mar 2026 – 26 Oct 2026 | |
| 29.87+5.66% | Buy 13 · Hold 2 · Sell 0 · 87% Buy | 63.2928.00–100.00 | +111.9%+33.42 USD | 2 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:52 ET | 1717 firms | avg 4 Aug23 Mar 2026 – 2 Oct 2026 | |
| 10.21+10.74% | Buy 13 · Hold 4 · Sell 0 · 76% Buy | 13.6710.00–18.00 | +33.9%+3.46 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:37 ET | 2019 firms | avg 24 Aug26 Mar 2026 – 30 Oct 2026 | |
| 12.25+8.89% | Buy 13 · Hold 2 · Sell 0 · 87% Buy | 28.8018.00–36.00 | +135.1%+16.55 USD | 22 OctPartial coverage · checked 6 Nov | 10 NovEstimated | Partial coverage6 Nov 06:14 ET | 1615 firms | avg 23 Jul28 Jan 2026 – 22 Oct 2026 | |
108IMAXIMAX | 47.67−0.96% | Buy 13 · Hold 4 · Sell 0 · 76% Buy | 60.2550.00–69.00 | +26.4%+12.58 USD | 23 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:50 ET | 1918 firms | avg 22 Sep22 May 2026 – 23 Oct 2026 |
109NCNONCINO | 22.67−2.33% | Buy 13 · Hold 7 · Sell 0 · 65% Buy | 23.7917.00–28.00 | +4.9%+1.12 USD | 16 OctPartial coverage · checked 6 Nov | 2 DecEstimated | Partial coverage6 Nov 02:53 ET | 2120 firms | avg 19 Aug14 May 2026 – 16 Oct 2026 |
| 15.30+3.10% | Buy 13 · Hold 1 · Sell 0 · 93% Buy | 34.8725.00–45.00 | +127.9%+19.57 USD | 16 OctPartial coverage · checked 6 Nov | 28 JanEstimated | Partial coverage6 Nov 05:50 ET | 1716 firms | avg 3 Sep8 Jun 2026 – 16 Oct 2026 | |
| 15.09−20.37% | Buy 13 · Hold 2 · Sell 0 · 87% Buy | 28.2322.00–35.00 | +87.1%+13.14 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:05 ET | 1616 firms | avg 15 Aug22 Jun 2026 – 28 Oct 2026 | |
| 6.39+6.32% | Buy 13 · Hold 4 · Sell 0 · 76% Buy | 15.5811.00–23.00 | +143.8%+9.19 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:04 ET | 1817 firms | avg 10 Jul10 Dec 2025 – 30 Oct 2026 | |
| 73.92−2.25% | Buy 13 · Hold 3 · Sell 0 · 81% Buy | 78.0068.00–85.00 | +5.5%+4.08 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:45 ET | 1818 firms | avg 2 Sep12 Feb 2026 – 29 Oct 2026 | |
| 22.32+3.60% | Buy 13 · Hold 1 · Sell 0 · 93% Buy | 28.5018.00–36.00 | +27.7%+6.18 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:46 ET | 1616 firms | avg 5 Jul20 Jan 2026 – 13 Oct 2026 | |
| 132.05+0.29% | Buy 13 · Hold 2 · Sell 0 · 87% Buy | 136.62112.00–147.00 | +3.5%+4.57 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:36 ET | 1616 firms | avg 23 Aug13 Jan 2026 – 27 Oct 2026 | |
| 10.08+12.06% | Buy 13 · Hold 7 · Sell 0 · 65% Buy | 11.298.50–15.00 | +12.0%+1.21 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:57 ET | 2121 firms | avg 20 Jul25 Feb 2026 – 19 Oct 2026 | |
| 9.54+1.81% | Buy 13 · Hold 1 · Sell 0 · 93% Buy | 40.1731.00–57.00 | +321.0%+30.63 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:55 ET | 1616 firms | avg 30 May9 Dec 2025 – 13 Oct 2026 | |
| 120.02+6.85% | Buy 13 · Hold 3 · Sell 0 · 81% Buy | 160.31125.00–200.00 | +33.6%+40.29 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:43 ET | 2019 firms | avg 24 Aug22 Jan 2026 – 27 Oct 2026 | |
| 37.72−0.03% | Buy 13 · Hold 1 · Sell 0 · 93% Buy | 35.6024.00–55.00 | −5.6%−2.12 USD | 7 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 03:01 ET | 1515 firms | avg 6 Jul27 Feb 2026 – 7 Oct 2026 | |
| 14.08+0.14% | Buy 13 · Hold 3 · Sell 0 · 81% Buy | 16.5813.25–18.50 | +17.8%+2.50 USD | 26 OctPartial coverage · checked 6 Nov | 28 JanEstimated | Partial coverage6 Nov 04:08 ET | 1817 firms | avg 25 Aug30 Jan 2026 – 26 Oct 2026 | |
121XNCRXENCOR | 35.75+4.99% | Buy 13 · Hold 3 · Sell 0 · 81% Buy | 40.5821.00–70.00 | +13.5%+4.83 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:57 ET | 1716 firms | avg 9 Sep26 Feb 2026 – 27 Oct 2026 |
122RZLTREZOLUTE | 3.88+6.59% | Buy 13 · Hold 0 · Sell 1 · 93% Buy | 9.806.00–15.00 | +152.6%+5.92 USD | 6 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:05 ET | 1515 firms | avg 17 Aug2 Jun 2026 – 6 Oct 2026 |
123SMSM ENERGY | 29.92+0.98% | Buy 13 · Hold 7 · Sell 1 · 62% Buy | 42.0530.00–58.00 | +40.5%+12.13 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:06 ET | 2423 firms | avg 13 Aug17 Mar 2026 – 21 Oct 2026 |
| 21.50+3.02% | Buy 13 · Hold 2 · Sell 1 · 81% Buy | 48.1724.00–69.00 | +124.0%+26.67 USD | 29 OctPartial coverage · checked 6 Nov | 10 NovEstimated | Partial coverage6 Nov 02:43 ET | 1919 firms | avg 30 Jul14 May 2026 – 29 Oct 2026 | |
| 49.60+1.49% | Buy 13 · Hold 0 · Sell 1 · 93% Buy | 70.4441.00–85.00 | +42.0%+20.84 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:38 ET | 1515 firms | avg 11 Aug25 Mar 2026 – 4 Nov 2026 | |
| 11.35+2.25% | Buy 13 · Hold 9 · Sell 5 · 48% Buy | 22.855.00–61.00 | +101.3%+11.50 USD | 6 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:56 ET | 3230 firms | avg 11 Jun7 Nov 2025 – 6 Oct 2026 | |
| 6.72+5.41% | Buy 12 · Hold 0 · Sell 0 · 100% Buy | 13.7010.00–20.00 | +103.9%+6.98 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:20 ET | 1313 firms | avg 10 Jul15 Mar 2026 – 21 Oct 2026 | |
| 1.04−4.59% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 7.392.00–14.00 | +610.1%+6.35 USD | 17 AugPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:07 ET | 1616 firms | avg 31 May13 Mar 2026 – 17 Aug 2026 | |
129ALMSALUMIS | 6.03+3.08% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 32.1115.00–46.00 | +432.5%+26.08 USD | 2 SepPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:11 ET | 1616 firms | avg 26 Jul25 Feb 2026 – 2 Sep 2026 |
| 29.50+6.81% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 38.7520.00–57.00 | +31.4%+9.25 USD | 15 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:46 ET | 1514 firms | avg 16 Jul3 Mar 2026 – 15 Oct 2026 | |
| 10.35+10.58% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 22.309.00–41.00 | +115.5%+11.95 USD | 9 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:01 ET | 1515 firms | avg 27 Jul4 Mar 2026 – 9 Oct 2026 | |
132ARDXARDELYX | 2.88−3.68% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 13.008.00–19.00 | +351.4%+10.12 USD | 18 AugPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:07 ET | 1413 firms | avg 15 Jul8 Jan 2026 – 18 Aug 2026 |
| 5.86+10.47% | Buy 12 · Hold 13 · Sell 0 · 48% Buy | 8.024.00–19.00 | +37.0%+2.17 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:14 ET | 2827 firms | avg 18 Jul10 Nov 2025 – 28 Oct 2026 | |
| 16.55+0.79% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 18.5414.00–28.00 | +12.0%+1.99 USD | 2 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:50 ET | 1918 firms | avg 29 Aug7 May 2026 – 2 Nov 2026 | |
| 6.93+4.52% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 41.0916.00–60.00 | +492.9%+34.16 USD | 26 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:11 ET | 1717 firms | avg 27 Jul9 Apr 2026 – 26 Oct 2026 | |
136AXGNAXOGEN | 50.02+2.61% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 57.9152.00–65.00 | +15.8%+7.89 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:51 ET | 1616 firms | avg 19 Oct30 Jul 2026 – 29 Oct 2026 |
| 15.70+1.36% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 24.1716.00–30.40 | +54.0%+8.47 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:10 ET | 1818 firms | avg 7 Sep22 Apr 2026 – 28 Oct 2026 | |
| 6.02+13.28% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 22.0010.00–35.00 | +265.8%+15.99 USD | 30 OctPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 05:58 ET | 1616 firms | avg 31 Jul16 Jan 2026 – 30 Oct 2026 | |
| 4.06+9.14% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 10.256.00–15.00 | +152.5%+6.19 USD | 23 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 08:14 ET | 1514 firms | avg 4 Aug2 Apr 2026 – 23 Oct 2026 | |
| 11.31+4.72% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 35.5526.00–47.00 | +214.3%+24.24 USD | 28 OctPartial coverage · checked 6 Nov | 14 NovConfirmed | Partial coverage6 Nov 06:11 ET | 1515 firms | avg 26 Jun20 Nov 2025 – 28 Oct 2026 | |
| 46.96+2.98% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 72.8356.00–91.00 | +55.1%+25.87 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:42 ET | 1616 firms | avg 3 Sep27 May 2026 – 19 Oct 2026 | |
| 158.36+0.47% | Buy 12 · Hold 11 · Sell 0 · 52% Buy | 178.47125.00–210.00 | +12.7%+20.11 USD | 28 OctPartial coverage · checked 6 Nov | 26 JanEstimated | Partial coverage6 Nov 02:37 ET | 2421 firms | avg 24 Sep24 Mar 2026 – 28 Oct 2026 | |
| 36.81+4.16% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 43.5038.00–50.00 | +18.2%+6.69 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:07 ET | 1716 firms | avg 6 Aug8 May 2026 – 28 Oct 2026 | |
| 67.02+4.04% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 97.5085.00–105.00 | +45.5%+30.48 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:55 ET | 1512 firms | avg 7 Aug25 Feb 2026 – 29 Oct 2026 | |
| 4.58+0.88% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 5.863.00–8.00 | +27.9%+1.28 USD | 18 AugPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:01 ET | 1717 firms | avg 1 Jun13 Nov 2025 – 18 Aug 2026 | |
146EVMNEVOMMUNE | 6.65+4.40% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 27.368.00–53.00 | +311.5%+20.71 USD | 20 OctPartial coverage · checked 6 Nov | 16 NovEstimated | Partial coverage6 Nov 08:14 ET | 1818 firms | avg 27 Jul18 Mar 2026 – 20 Oct 2026 |
| 45.04+15.87% | Buy 12 · Hold 2 · Sell 0 · 86% Buy | 51.3125.00–66.00 | +13.9%+6.27 USD | 12 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:47 ET | 1716 firms | avg 13 Jul26 Feb 2026 – 12 Oct 2026 | |
| 19.07−0.42% | Buy 12 · Hold 3 · Sell 0 · 80% Buy | 21.7120.00–24.00 | +13.8%+2.64 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:03 ET | 1615 firms | avg 29 Jul13 May 2026 – 19 Oct 2026 | |
| 12.86−1.98% | Buy 12 · Hold 1 · Sell 0 · 92% Buy | 18.0014.00–22.00 | +40.0%+5.14 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:13 ET | 1515 firms | avg 25 Jul24 Feb 2026 – 21 Oct 2026 | |
| 8.04+3.88% | Buy 12 · Hold 4 · Sell 0 · 75% Buy | 13.857.00–20.00 | +72.2%+5.81 USD | 26 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:09 ET | 1715 firms | avg 6 Sep7 May 2026 – 26 Oct 2026 | |
- AVBP#101ARRIVENT BIOPHARMA13.64+11.53%
Buy 13 · Hold 1 · Sell 0 · 93% Buy
Target 28.15 (18.00–50.00)+106.4%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 6 Mar 2026 – 27 Oct 2026 · avg 4 Sep 2026
- Analysts
- 16 analysts · 14 firms
- Next earnings
- 16 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- BKV#102BKV17.55−2.99%
Buy 13 · Hold 0 · Sell 0 · 100% Buy
Target 34.36 (29.00–39.00)+95.8%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 5 Feb 2026 – 19 Oct 2026 · avg 11 Jul 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BOOT#103BOOT BARN HOLDINGS130.96−5.66%
Buy 13 · Hold 2 · Sell 0 · 87% Buy
Target 187.79 (140.00–225.00)+43.4%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 14 May 2026 – 30 Oct 2026 · avg 15 Sep 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CATX#104PERSPECTIVE THERAPEUTICS0.84+6.54%
Buy 13 · Hold 3 · Sell 0 · 81% Buy
Target 11.60 (5.00–15.00)+1,281.0%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 18 Mar 2026 – 26 Oct 2026 · avg 23 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- CLDX#105CELLDEX THERAPEUTICS29.87+5.66%
Buy 13 · Hold 2 · Sell 0 · 87% Buy
Target 63.29 (28.00–100.00)+111.9%
Details
- Latest target report
- 2 Oct 2026
- Report dates
- 23 Mar 2026 – 2 Oct 2026 · avg 4 Aug 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- COMP#106COMPASS INC CLASS A10.21+10.74%
Buy 13 · Hold 4 · Sell 0 · 76% Buy
Target 13.67 (10.00–18.00)+33.9%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 26 Mar 2026 – 30 Oct 2026 · avg 24 Aug 2026
- Analysts
- 20 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- FDMT#1074D MOLECULAR THERAPEUTICS INC12.25+8.89%
Buy 13 · Hold 2 · Sell 0 · 87% Buy
Target 28.80 (18.00–36.00)+135.1%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 28 Jan 2026 – 22 Oct 2026 · avg 23 Jul 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- 10 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- IMAX#108IMAX47.67−0.96%
Buy 13 · Hold 4 · Sell 0 · 76% Buy
Target 60.25 (50.00–69.00)+26.4%
Details
- Latest target report
- 23 Oct 2026
- Report dates
- 22 May 2026 – 23 Oct 2026 · avg 22 Sep 2026
- Analysts
- 19 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- NCNO#109NCINO22.67−2.33%
Buy 13 · Hold 7 · Sell 0 · 65% Buy
Target 23.79 (17.00–28.00)+4.9%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 14 May 2026 – 16 Oct 2026 · avg 19 Aug 2026
- Analysts
- 21 analysts · 20 firms
- Next earnings
- 2 Dec · Estimated
- Research
- Partial coverage · checked 6 Nov
- NRIX#110NURIX THERAPEUTICS15.30+3.10%
Buy 13 · Hold 1 · Sell 0 · 93% Buy
Target 34.87 (25.00–45.00)+127.9%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 8 Jun 2026 – 16 Oct 2026 · avg 3 Sep 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- 28 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- OMDA#111OMADA HEALTH15.09−20.37%
Buy 13 · Hold 2 · Sell 0 · 87% Buy
Target 28.23 (22.00–35.00)+87.1%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 22 Jun 2026 – 28 Oct 2026 · avg 15 Aug 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PUMP#112PROPETRO HOLDING6.39+6.32%
Buy 13 · Hold 4 · Sell 0 · 76% Buy
Target 15.58 (11.00–23.00)+143.8%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 10 Dec 2025 – 30 Oct 2026 · avg 10 Jul 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- QTWO#113Q2 HOLDINGS INC73.92−2.25%
Buy 13 · Hold 3 · Sell 0 · 81% Buy
Target 78.00 (68.00–85.00)+5.5%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 12 Feb 2026 – 29 Oct 2026 · avg 2 Sep 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RELY#114REMITLY GLOBAL22.32+3.60%
Buy 13 · Hold 1 · Sell 0 · 93% Buy
Target 28.50 (18.00–36.00)+27.7%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 20 Jan 2026 – 13 Oct 2026 · avg 5 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RHP#115RYMAN HOSPITALITY PROPERTIES REIT132.05+0.29%
Buy 13 · Hold 2 · Sell 0 · 87% Buy
Target 136.62 (112.00–147.00)+3.5%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 13 Jan 2026 – 27 Oct 2026 · avg 23 Aug 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SHLS#116SHOALS TECHNOLOGIES GROUP CLASS A10.08+12.06%
Buy 13 · Hold 7 · Sell 0 · 65% Buy
Target 11.29 (8.50–15.00)+12.0%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 25 Feb 2026 – 19 Oct 2026 · avg 20 Jul 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SNDX#117SYNDAX PHARMACEUTICALS9.54+1.81%
Buy 13 · Hold 1 · Sell 0 · 93% Buy
Target 40.17 (31.00–57.00)+321.0%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 9 Dec 2025 – 13 Oct 2026 · avg 30 May 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SPHR#118SPHERE ENTERTAINMENT CLASS A120.02+6.85%
Buy 13 · Hold 3 · Sell 0 · 81% Buy
Target 160.31 (125.00–200.00)+33.6%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 22 Jan 2026 – 27 Oct 2026 · avg 24 Aug 2026
- Analysts
- 20 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- VIA#119VIA TRANSPORTATION CLASS A37.72−0.03%
Buy 13 · Hold 1 · Sell 0 · 93% Buy
Target 35.60 (24.00–55.00)−5.6%
Details
- Latest target report
- 7 Oct 2026
- Report dates
- 27 Feb 2026 – 7 Oct 2026 · avg 6 Jul 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- VLY#120VALLEY NATIONAL14.08+0.14%
Buy 13 · Hold 3 · Sell 0 · 81% Buy
Target 16.58 (13.25–18.50)+17.8%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 30 Jan 2026 – 26 Oct 2026 · avg 25 Aug 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- 28 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- XNCR#121XENCOR35.75+4.99%
Buy 13 · Hold 3 · Sell 0 · 81% Buy
Target 40.58 (21.00–70.00)+13.5%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 26 Feb 2026 – 27 Oct 2026 · avg 9 Sep 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RZLT#122REZOLUTE3.88+6.59%
Buy 13 · Hold 0 · Sell 1 · 93% Buy
Target 9.80 (6.00–15.00)+152.6%
Details
- Latest target report
- 6 Oct 2026
- Report dates
- 2 Jun 2026 – 6 Oct 2026 · avg 17 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SM#123SM ENERGY29.92+0.98%
Buy 13 · Hold 7 · Sell 1 · 62% Buy
Target 42.05 (30.00–58.00)+40.5%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 17 Mar 2026 – 21 Oct 2026 · avg 13 Aug 2026
- Analysts
- 24 analysts · 23 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TNGX#124TANGO THERAPEUTICS21.50+3.02%
Buy 13 · Hold 2 · Sell 1 · 81% Buy
Target 48.17 (24.00–69.00)+124.0%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 14 May 2026 – 29 Oct 2026 · avg 30 Jul 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- 10 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- TVTX#125TRAVERE THERAPEUTICS49.60+1.49%
Buy 13 · Hold 0 · Sell 1 · 93% Buy
Target 70.44 (41.00–85.00)+42.0%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 25 Mar 2026 – 4 Nov 2026 · avg 11 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- NTLA#126INTELLIA THERAPEUTICS11.35+2.25%
Buy 13 · Hold 9 · Sell 5 · 48% Buy
Target 22.85 (5.00–61.00)+101.3%
Details
- Latest target report
- 6 Oct 2026
- Report dates
- 7 Nov 2025 – 6 Oct 2026 · avg 11 Jun 2026
- Analysts
- 32 analysts · 30 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ACHV#127ACHIEVE LIFE SCIENCES6.72+5.41%
Buy 12 · Hold 0 · Sell 0 · 100% Buy
Target 13.70 (10.00–20.00)+103.9%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 15 Mar 2026 – 21 Oct 2026 · avg 10 Jul 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ALLO#128ALLOGENE THERAPEUTICS1.04−4.59%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 7.39 (2.00–14.00)+610.1%
Details
- Latest target report
- 17 Aug 2026
- Report dates
- 13 Mar 2026 – 17 Aug 2026 · avg 31 May 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ALMS#129ALUMIS6.03+3.08%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 32.11 (15.00–46.00)+432.5%
Details
- Latest target report
- 2 Sep 2026
- Report dates
- 25 Feb 2026 – 2 Sep 2026 · avg 26 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- AMLX#130AMYLYX PHARMACEUTICALS29.50+6.81%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 38.75 (20.00–57.00)+31.4%
Details
- Latest target report
- 15 Oct 2026
- Report dates
- 3 Mar 2026 – 15 Oct 2026 · avg 16 Jul 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ARCT#131ARCTURUS THERAPEUTICS HOLDINGS INC10.35+10.58%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 22.30 (9.00–41.00)+115.5%
Details
- Latest target report
- 9 Oct 2026
- Report dates
- 4 Mar 2026 – 9 Oct 2026 · avg 27 Jul 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ARDX#132ARDELYX2.88−3.68%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 13.00 (8.00–19.00)+351.4%
Details
- Latest target report
- 18 Aug 2026
- Report dates
- 8 Jan 2026 – 18 Aug 2026 · avg 15 Jul 2026
- Analysts
- 14 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ARRY#133ARRAY TECHNOLOGIES INC5.86+10.47%
Buy 12 · Hold 13 · Sell 0 · 48% Buy
Target 8.02 (4.00–19.00)+37.0%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 10 Nov 2025 – 28 Oct 2026 · avg 18 Jul 2026
- Analysts
- 28 analysts · 27 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- AVPT#134AVEPOINT CLASS A16.55+0.79%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 18.54 (14.00–28.00)+12.0%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 7 May 2026 – 2 Nov 2026 · avg 29 Aug 2026
- Analysts
- 19 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- AVTX#135AVALO THERAPEUTICS6.93+4.52%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 41.09 (16.00–60.00)+492.9%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 9 Apr 2026 – 26 Oct 2026 · avg 27 Jul 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- AXGN#136AXOGEN50.02+2.61%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 57.91 (52.00–65.00)+15.8%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 30 Jul 2026 – 29 Oct 2026 · avg 19 Oct 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BBNX#137BETA BIONICS15.70+1.36%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 24.17 (16.00–30.40)+54.0%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 22 Apr 2026 – 28 Oct 2026 · avg 7 Sep 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BTDR#138BITDEER TECHNOLOGIES GROUP CLASS A6.02+13.28%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 22.00 (10.00–35.00)+265.8%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 16 Jan 2026 – 30 Oct 2026 · avg 31 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- CAMP#139CAMP4 THERAPEUTICS CORP4.06+9.14%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 10.25 (6.00–15.00)+152.5%
Details
- Latest target report
- 23 Oct 2026
- Report dates
- 2 Apr 2026 – 23 Oct 2026 · avg 4 Aug 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CGEM#140CULLINAN THERAPEUTICS11.31+4.72%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 35.55 (26.00–47.00)+214.3%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 20 Nov 2025 – 28 Oct 2026 · avg 26 Jun 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 14 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- CRC#141CALIFORNIA RESOURCES46.96+2.98%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 72.83 (56.00–91.00)+55.1%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 27 May 2026 – 19 Oct 2026 · avg 3 Sep 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CVLT#142COMMVAULT SYSTEMS158.36+0.47%
Buy 12 · Hold 11 · Sell 0 · 52% Buy
Target 178.47 (125.00–210.00)+12.7%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 24 Mar 2026 – 28 Oct 2026 · avg 24 Sep 2026
- Analysts
- 24 analysts · 21 firms
- Next earnings
- 26 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- EE#143EXCELERATE ENERGY CLASS A36.81+4.16%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 43.50 (38.00–50.00)+18.2%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 8 May 2026 – 28 Oct 2026 · avg 6 Aug 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ESTA#144ESTABLISHMENT LABS INC67.02+4.04%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 97.50 (85.00–105.00)+45.5%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 25 Feb 2026 – 29 Oct 2026 · avg 7 Aug 2026
- Analysts
- 15 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- EVH#145EVOLENT HEALTH CLASS A4.58+0.88%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 5.86 (3.00–8.00)+27.9%
Details
- Latest target report
- 18 Aug 2026
- Report dates
- 13 Nov 2025 – 18 Aug 2026 · avg 1 Jun 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- EVMN#146EVOMMUNE6.65+4.40%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 27.36 (8.00–53.00)+311.5%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 18 Mar 2026 – 20 Oct 2026 · avg 27 Jul 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- 16 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- EWTX#147EDGEWISE THERAPEUTICS45.04+15.87%
Buy 12 · Hold 2 · Sell 0 · 86% Buy
Target 51.31 (25.00–66.00)+13.9%
Details
- Latest target report
- 12 Oct 2026
- Report dates
- 26 Feb 2026 – 12 Oct 2026 · avg 13 Jul 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- FVR#148FRONTVIEW REIT19.07−0.42%
Buy 12 · Hold 3 · Sell 0 · 80% Buy
Target 21.71 (20.00–24.00)+13.8%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 13 May 2026 – 19 Oct 2026 · avg 29 Jul 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- FWRG#149FIRST WATCH RESTAURANT GROUP12.86−1.98%
Buy 12 · Hold 1 · Sell 0 · 92% Buy
Target 18.00 (14.00–22.00)+40.0%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 24 Feb 2026 – 21 Oct 2026 · avg 25 Jul 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- IOVA#150IOVANCE BIOTHERAPEUTICS INC8.04+3.88%
Buy 12 · Hold 4 · Sell 0 · 75% Buy
Target 13.85 (7.00–20.00)+72.2%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 7 May 2026 – 26 Oct 2026 · avg 6 Sep 2026
- Analysts
- 17 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
Showing 101–150 of 1,952Load more
About the Russell 2000 analyst ratings
US small-cap stocks in the Russell 2000. Smaller companies usually have fewer analysts.. For each stock Analyst Radar counts the latest Buy, Hold or Sell rating of every analyst who covers it within the chosen window (one vote per analyst) and averages their price targets in US dollars. Upside is the average target against the current price; the range is the lowest and highest target. The stocks our model scores highest are collected in Radar picks. Research is refreshed daily and prices stream live during the US session.
A summary of analyst opinion, not investment advice.